Changes in CEVEC’s Supervisory Board
CEVEC Pharmaceuticals announced that Rainer Christine has joined its supervisory board. Rainer Christine was the CEO and co-founder of the German-American biotools company amaxa and plays an active role in the life sciences related venture capital industry. Under Rainer’s leadership amaxa grew from start-up in 1998 to a full-fledged and profitable life science company with strong scientific and commercial activities, 160 staff in Europe and the US, and more than EUR 100 million in cumulative sales. In 2008, amaxa was successfully sold to Lonza, a global supplier to the life-science industry.
At the same time, Gangolf Ehlen, previous Chairman of CEVEC’s supervisory board and lead investor from Venture Capital Beteiligungen Sparkasse KölnBonn, will resign from the CEVEC board to pursue a new role at Sparkasse KölnBonn. New chairman of the board will be the current vice-chairman Karlheinz Schmelig, Managing Partner at current lead investor Creathor Venture.
The CEVEC supervisory board changes are accompanied by the successful first closing of a further financing round to expand CEVECs vaccine platform business.
Organizations
Other news from the department people

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.